Stocks under Consideration: VWR Corporation (VWR), Ambev S.A. (ABEV)

Owen Stevens
May 6, 2017

Several research analysts recently commented on VWR shares. A rating of 4 or 5 would represent a Sell recommendation. TheStreet upgraded VWR Corp from a "c" rating to a "b-" rating in a report on Wednesday, April 19th.

Just yesterday VWR Corp (NASDAQ:VWR) traded -2.39% lower at $33.26. The current share price indicates that stock is 5.89% away from its one year high and is moving 37.67% ahead of its 52-week low. The company's 50-day moving average is $28.14 and its 200 day moving average is $26.81.

Price targets show what analysts believes a stock will be worth at the end of a certain time period. The correct version of this news story can be viewed at

Analysts await VWR Corporation (NASDAQ:VWR) to report earnings on May, 05 for the fiscal quarter ending Mar 2017. The Higher end of the revenue forecast is $1.17 Billion, while the Lower end of the forecast is $1.13 Billion. VWR Corp (NASDAQ:VWR) has a Return on Assets (ROA) of 3%. VWR Corp's revenue for the quarter was up 3.7% compared to the same quarter previous year. Equities research analysts predict that VWR Corp will post $1.81 earnings per share for the current fiscal year. The company had a trading volume of 1,502,585,537 shares. VWR Corp earned a coverage optimism score of 0.04 on AlphaOne's scale.

A stock rating usually tells investors how well a stock's market value relates to what analysts think is a fair value for the stock, based on an independent evaluation of the company. Fox Run Management L.L.C. acquired a new stake in shares of VWR Corp during the first quarter worth about $742,000. Corsair Capital Management L.P. now owns 555,116 shares of the medical research company's stock worth $15,731,000 after buying an additional 8,305 shares in the last quarter. M&T Bank Corp boosted its stake in VWR Corp by 4.5% in the third quarter. An Avantor spokeswoman later said the second figure includes the value of the company plus its debt while the Reuters number is likely its market capitalization.

It's even better if the EPS growth rate has been accelerating in recent quarters and years. In contrast, VWR's 52 week high hovers at $31.75 with its current distance from 52 week high value is 5.89%. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of United States and global copyright laws.

The deal is created to enable the combined company to serve customers from research through production by joining Avantor's strengths in cGMP manufacturing processes and significant exposure to emerging markets with VWR's focus on providing product and service solutions to laboratory and production customers in the Americas and Europe.

Avantor plans to acquire VWR for approximately $6.4 billion cash, in a deal the companies said today would create a combined global provider of consumables-focused solutions and services to life sciences and advanced technologies businesses, as well as education, government, and research institutions.

Other reports by VgToday

Discuss This Article